BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Marchetti M. COVID-19-driven endothelial damage: complement, HIF-1, and ABL2 are potential pathways of damage and targets for cure. Ann Hematol. 2020;99:1701-1707. [PMID: 32583086 DOI: 10.1007/s00277-020-04138-8] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 23.0] [Reference Citation Analysis]
Number Citing Articles
1 Macciò A, Madeddu C, Caocci G, Oppi S, La Nasa G. Defibrotide in the COVID-19 coagulopathy: What is the timing? J Thromb Haemost 2020;18:3113-5. [PMID: 32945111 DOI: 10.1111/jth.15100] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Goswami J, MacArthur TA, Sridharan M, Pruthi RK, McBane RD 2nd, Witzig TE, Park MS. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy. Shock 2021;55:700-16. [PMID: 33378321 DOI: 10.1097/SHK.0000000000001680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
3 Kaur S, Tripathi DM, Yadav A. The Enigma of Endothelium in COVID-19. Front Physiol 2020;11:989. [PMID: 32848893 DOI: 10.3389/fphys.2020.00989] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 14.0] [Reference Citation Analysis]
4 Savastano A, Crincoli E, Savastano MC, Younis S, Gambini G, De Vico U, Cozzupoli GM, Culiersi C, Rizzo S, Gemelli Against Covid-Post-Acute Care Study Group. Peripapillary Retinal Vascular Involvement in Early Post-COVID-19 Patients. J Clin Med 2020;9:E2895. [PMID: 32911619 DOI: 10.3390/jcm9092895] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
5 Ullah I, Sohail A, Shah MUFA, Khurshid M, Diwan MN, Qadir A, Irfan M. Central Retinal Vein Occlusion in patients with COVID-19 infection: A systematic review. Ann Med Surg (Lond) 2021;71:102898. [PMID: 34659743 DOI: 10.1016/j.amsu.2021.102898] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Machado BH, Paton JFR. Relevance of carotid bodies in COVID-19: A hypothetical viewpoint. Auton Neurosci 2021;233:102810. [PMID: 33894532 DOI: 10.1016/j.autneu.2021.102810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Yu J, Yuan X, Chen H, Chaturvedi S, Braunstein EM, Brodsky RA. Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition. Blood 2020;136:2080-9. [PMID: 32877502 DOI: 10.1182/blood.2020008248] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 40.0] [Reference Citation Analysis]
8 Barbosa LC, Gonçalves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 2021;137:106829. [PMID: 33422689 DOI: 10.1016/j.vph.2021.106829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
9 Tomazou M, Bourdakou MM, Minadakis G, Zachariou M, Oulas A, Karatzas E, Loizidou E, Kakouri A, Christodoulou C, Savva K, Zanti M, Onisiforou A, Afxenti S, Richter J, Christodoulou CG, Kyprianou T, Kolios G, Dietis N, Spyrou GM. Multi-omics data integration and network-based analysis drives a multiplex drug repurposing approach to a shortlist of candidate drugs against COVID-19. Brief Bioinform 2021:bbab114. [PMID: 34009288 DOI: 10.1093/bib/bbab114] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mishra R, Behera LM, Rana S. Binding of raloxifene to human complement fragment 5a (hC5a): a perspective on cytokine storm and COVID19. J Biomol Struct Dyn 2020;:1-13. [PMID: 32930050 DOI: 10.1080/07391102.2020.1820381] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
12 Xu B, Li G, Guo J, Ikezoe T, Kasirajan K, Zhao S, Dalman RL. Angiotensin-converting enzyme 2, coronavirus disease 2019, and abdominal aortic aneurysms. J Vasc Surg 2021:S0741-5214(21)00195-6. [PMID: 33600934 DOI: 10.1016/j.jvs.2021.01.051] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Shamsah MA, Bitar ZI, Alfoudri H. Right atrial thrombus in a patient with COVID-19 pneumonia: a case report. Eur Heart J Case Rep 2020;4:1-4. [PMID: 33089061 DOI: 10.1093/ehjcr/ytaa296] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Çakmak F, Demirbuga A, Demirkol D, Gümüş S, Torun SH, Kayaalp GK, Ömeroglu RE, Somer A, Uysalol M, Yıldız R, Ayaz NA. Nailfold capillaroscopy: A sensitive method for evaluating microvascular involvement in children with SARS-CoV-2 infection. Microvasc Res 2021;138:104196. [PMID: 34097919 DOI: 10.1016/j.mvr.2021.104196] [Reference Citation Analysis]
15 Abrishami M, Hassanpour K, Hosseini S, Shoeibi N, Ansari-astaneh MR, Emamverdian Z, Gharib B, Amini N, Abrishami M, Mwanza J. Peripapillary Nerve Fiber Layer Thickness and Optic Nerve Head Parameters in Patients Recovered from COVID-19: A Longitudinal Study. Journal of Ophthalmology 2022;2022:1-7. [DOI: 10.1155/2022/4643973] [Reference Citation Analysis]
16 Vassiliou AG, Keskinidou C, Jahaj E, Gallos P, Dimopoulou I, Kotanidou A, Orfanos SE. ICU Admission Levels of Endothelial Biomarkers as Predictors of Mortality in Critically Ill COVID-19 Patients. Cells 2021;10:186. [PMID: 33477776 DOI: 10.3390/cells10010186] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
17 Savastano MC, Gambini G, Cozzupoli GM, Crincoli E, Savastano A, De Vico U, Culiersi C, Falsini B, Martelli F, Minnella AM, Landi F, Pagano FC, Rizzo S; Gemelli Against COVID-19 Post-Acute Care Study Group. Retinal capillary involvement in early post-COVID-19 patients: a healthy controlled study. Graefes Arch Clin Exp Ophthalmol 2021;259:2157-65. [PMID: 33523252 DOI: 10.1007/s00417-020-05070-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
18 Halawa S, Pullamsetti SS, Bangham CRM, Stenmark KR, Dorfmüller P, Frid MG, Butrous G, Morrell NW, de Jesus Perez VA, Stuart DI, O'Gallagher K, Shah AM, Aguib Y, Yacoub MH. Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective. Nat Rev Cardiol 2021. [PMID: 34873286 DOI: 10.1038/s41569-021-00640-2] [Reference Citation Analysis]
19 Santoso CS, Li Z, Rottenberg JT, Liu X, Shen VX, Fuxman Bass JI. Therapeutic Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19. Front Pharmacol 2021;12:673485. [PMID: 34163359 DOI: 10.3389/fphar.2021.673485] [Reference Citation Analysis]
20 Meyer AA, Mathews EH, Gous AGS, Mathews MJ. Using a Systems Approach to Explore the Mechanisms of Interaction Between Severe Covid-19 and Its Coronary Heart Disease Complications. Front Cardiovasc Med 2022;9:737592. [DOI: 10.3389/fcvm.2022.737592] [Reference Citation Analysis]
21 Rashid M, Wu J, Timmis A, Curzen N, Clarke S, Zaman A, Nolan J, Shoaib A, Mohamed MO, de Belder MA, Deanfield J, Gale CP, Mamas MA. Outcomes of COVID-19-positive acute coronary syndrome patients: A multisource electronic healthcare records study from England. J Intern Med 2021;290:88-100. [PMID: 33462815 DOI: 10.1111/joim.13246] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
22 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
23 Lai Y, Han T, Lao Z, Li G, Xiao J, Liu X. Phillyrin for COVID-19 and Influenza Co-infection: A Potential Therapeutic Strategy Targeting Host Based on Bioinformatics Analysis. Front Pharmacol 2021;12:754241. [PMID: 34803696 DOI: 10.3389/fphar.2021.754241] [Reference Citation Analysis]
24 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
25 Elyaspour Z, Zibaeenezhad MJ, Razmkhah M, Razeghian-Jahromi I. Is It All About Endothelial Dysfunction and Thrombosis Formation? The Secret of COVID-19. Clin Appl Thromb Hemost 2021;27:10760296211042940. [PMID: 34693754 DOI: 10.1177/10760296211042940] [Reference Citation Analysis]
26 Voicu S, Ketfi C, Stépanian A, Chousterman BG, Mohamedi N, Siguret V, Mebazaa A, Mégarbane B, Bonnin P. Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol 2020;11:608788. [PMID: 33488398 DOI: 10.3389/fphys.2020.608788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Liu PJ, Balfe P, McKeating JA, Schilling M. Oxygen Sensing and Viral Replication: Implications for Tropism and Pathogenesis. Viruses 2020;12:E1213. [PMID: 33113858 DOI: 10.3390/v12111213] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
28 Nouailles G, Wyler E, Pennitz P, Postmus D, Vladimirova D, Kazmierski J, Pott F, Dietert K, Muelleder M, Farztdinov V, Obermayer B, Wienhold SM, Andreotti S, Hoefler T, Sawitzki B, Drosten C, Sander LE, Suttorp N, Ralser M, Beule D, Gruber AD, Goffinet C, Landthaler M, Trimpert J, Witzenrath M. Temporal omics analysis in Syrian hamsters unravel cellular effector responses to moderate COVID-19. Nat Commun 2021;12:4869. [PMID: 34381043 DOI: 10.1038/s41467-021-25030-7] [Reference Citation Analysis]
29 Janaszak-Jasiecka A, Siekierzycka A, Płoska A, Dobrucki IT, Kalinowski L. Endothelial Dysfunction Driven by Hypoxia-The Influence of Oxygen Deficiency on NO Bioavailability. Biomolecules 2021;11:982. [PMID: 34356605 DOI: 10.3390/biom11070982] [Reference Citation Analysis]
30 Huang Y, Zheng WJ, Ni YS, Li MS, Chen JK, Liu XH, Tan XH, Li JQ. Therapeutic mechanism of Toujie Quwen granules in COVID-19 based on network pharmacology. BioData Min 2020;13:15. [PMID: 32983259 DOI: 10.1186/s13040-020-00225-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
31 Haffke M, Freitag H, Rudolf G, Seifert M, Doehner W, Scherbakov N, Hanitsch L, Wittke K, Bauer S, Konietschke F, Paul F, Bellmann-Strobl J, Kedor C, Scheibenbogen C, Sotzny F. Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). J Transl Med 2022;20:138. [PMID: 35317812 DOI: 10.1186/s12967-022-03346-2] [Reference Citation Analysis]
32 Habibi M, Taheri G. Topological network based drug repurposing for coronavirus 2019. PLoS One 2021;16:e0255270. [PMID: 34324563 DOI: 10.1371/journal.pone.0255270] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Yılmaz Tuğan B, Sönmez HE, Atay K, Başar EZ, Özkan B, Karabaş L. Quantitative analysis of preclinical ocular microvascular changes in Multisystemic Inflammatory Syndrome in Children (MIS-C) detected by optical coherence tomography angiography. Eye (Lond) 2022. [PMID: 35487962 DOI: 10.1038/s41433-022-02081-8] [Reference Citation Analysis]
34 Jahani M, Dokaneheifard S, Mansouri K. Hypoxia: A key feature of COVID-19 launching activation of HIF-1 and cytokine storm. J Inflamm (Lond) 2020;17:33. [PMID: 33139969 DOI: 10.1186/s12950-020-00263-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 14.5] [Reference Citation Analysis]
35 Santoso CS, Li Z, Rottenberg JT, Liu X, Shen VX, Bass JIF. In vitro Targeting of Transcription Factors to Control the Cytokine Release Syndrome in COVID-19. bioRxiv 2020:2020. [PMID: 33398281 DOI: 10.1101/2020.12.29.424728] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
36 Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, Crowson AN, Laurence J, Nuovo G. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol 2021;50:151645. [PMID: 33248385 DOI: 10.1016/j.anndiagpath.2020.151645] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
37 Hamed ME, Naeem A, Alkadi H, Alamri AA, AlYami AS, AlJuryyan A, Alturaiki W, Enani M, Al-Shouli ST, Assiri AM, Alosaimi B. Elevated Expression Levels of Lung Complement Anaphylatoxin, Neutrophil Chemoattractant Chemokine IL-8, and RANTES in MERS-CoV-Infected Patients: Predictive Biomarkers for Disease Severity and Mortality. J Clin Immunol 2021. [PMID: 34232441 DOI: 10.1007/s10875-021-01061-z] [Reference Citation Analysis]
38 Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatol Ther 2021;34:e14565. [PMID: 33219572 DOI: 10.1111/dth.14565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Umbrajkar S, Stankowski RV, Rezkalla S, Kloner RA. Cardiovascular Health and Disease in the Context of COVID-19. Cardiol Res 2021;12:67-79. [PMID: 33738009 DOI: 10.14740/cr1199] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
40 Shadyro O, Samovich S, Edimecheva I, Novitsky R, Khrutskin V, Ihnatovich L, Boreko E, Dubovik B. Potential role of free-radical processes in biomolecules damage during COVID-19 and ways of their regulation. Free Radic Res 2021;:1-12. [PMID: 34085882 DOI: 10.1080/10715762.2021.1938024] [Reference Citation Analysis]
41 Prada F, Cogliati C, Wu MA, Durando G, Montano N, Gaspare Vetrano I, Calliada F, Bastianello S, Pichiecchio A, Padilla F. Can Low-Intensity Pulsed Ultrasound Treat Discrete Pulmonary Lesions in Patients With COVID-19? J Ultrasound Med 2021;40:1445-50. [PMID: 33073873 DOI: 10.1002/jum.15522] [Reference Citation Analysis]
42 Schieffer E, Schieffer B, Hilfiker-Kleiner D. [Cardiovascular diseases and COVID-19 : Pathophysiology, complications and treatment]. Herz 2021;46:107-14. [PMID: 33394058 DOI: 10.1007/s00059-020-05013-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Sun X, Sun BL, Sammani S, Bermudez T, Dudek SM, Camp SM, Garcia JGN. Genetic and epigenetic regulation of the non-muscle myosin light chain kinase isoform by lung inflammatory factors and mechanical stress. Clin Sci (Lond) 2021;135:963-77. [PMID: 33792658 DOI: 10.1042/CS20201448] [Reference Citation Analysis]
44 Sen S, Kannan NB, Kumar J, Rajan RP, Kumar K, Baliga G, Reddy H, Upadhyay A, Ramasamy K. Retinal manifestations in patients with SARS-CoV-2 infection and pathogenetic implications: a systematic review. Int Ophthalmol 2021. [PMID: 34379290 DOI: 10.1007/s10792-021-01996-7] [Reference Citation Analysis]
45 Alosaimi B, Mubarak A, Hamed ME, Almutairi AZ, Alrashed AA, AlJuryyan A, Enani M, Alenzi FQ, Alturaiki W. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality. Front Immunol 2021;12:668725. [PMID: 34276659 DOI: 10.3389/fimmu.2021.668725] [Reference Citation Analysis]
46 Calderón-Garcidueñas L, Torres-Jardón R, Franco-Lira M, Kulesza R, González-Maciel A, Reynoso-Robles R, Brito-Aguilar R, García-Arreola B, Revueltas-Ficachi P, Barrera-Velázquez JA, García-Alonso G, García-Rojas E, Mukherjee PS, Delgado-Chávez R. Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution. J Alzheimers Dis 2020;78:479-503. [PMID: 32955466 DOI: 10.3233/JAD-200891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
47 Peng Y, Tao H, Satyanarayanan SK, Jin K, Su H. A Comprehensive Summary of the Knowledge on COVID-19 Treatment. Aging Dis 2021;12:155-91. [PMID: 33532135 DOI: 10.14336/AD.2020.1124] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
48 Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta-analysis. Thromb J 2021;19:32. [PMID: 34011381 DOI: 10.1186/s12959-021-00284-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Abohamr SI, Abdulrahim AE, Hussein NM, Elsheikh E, ALhindi DA, Saadeddin HM, Abazid RM. Multimodality imaging in COVID19 patient with large mobile RV thrombus protruding into the pulmonary trunk with bilateral pulmonary embolism. J Cardiol Cases 2021;24:215-7. [PMID: 34518773 DOI: 10.1016/j.jccase.2021.08.008] [Reference Citation Analysis]
50 Rezkalla SH, Kloner RA. Viral myocarditis: 1917-2020: From the Influenza A to the COVID-19 pandemics. Trends Cardiovasc Med 2021;31:163-9. [PMID: 33383171 DOI: 10.1016/j.tcm.2020.12.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
51 AbdelMassih A, Yacoub E, Husseiny RJ, Kamel A, Hozaien R, El Shershaby M, Rajab M, Yacoub S, Eid MA, Elahmady M, Gadalla M, Mokhtar S, Hassan AA, Abou-Zeid AS, Hussein M, Aboushadi N, Emad N, Zahra N, Hassan A, Hussein E, Ibrahim N, El Nahhas N, Elahmady T, Khallaf M, Mustafa H, Anis N, Albehairy M, Hanna F, Moris L, Ye J. Hypoxia-inducible factor (HIF): The link between obesity and COVID-19. Obes Med 2021;22:100317. [PMID: 33521378 DOI: 10.1016/j.obmed.2020.100317] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
52 Viswanathan V, Puvvula A, Jamthikar AD, Saba L, Johri AM, Kotsis V, Khanna NN, Dhanjil SK, Majhail M, Misra DP, Agarwal V, Kitas GD, Sharma AM, Kolluri R, Naidu S, Suri JS. Bidirectional link between diabetes mellitus and coronavirus disease 2019 leading to cardiovascular disease: A narrative review. World J Diabetes 2021; 12(3): 215-237 [PMID: 33758644 DOI: 10.4239/wjd.v12.i3.215] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
53 Francistiová L, Klepe A, Curley G, Gulya K, Dinnyés A, Filkor K. Cellular and Molecular Effects of SARS-CoV-2 Linking Lung Infection to the Brain. Front Immunol 2021;12:730088. [PMID: 34484241 DOI: 10.3389/fimmu.2021.730088] [Reference Citation Analysis]
54 Zhou X, Cheng Z, Hu Y. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management. J Pers Med 2021;11:1328. [PMID: 34945800 DOI: 10.3390/jpm11121328] [Reference Citation Analysis]
55 Rahman A, Tabassum T, Araf Y, Al Nahid A, Ullah MA, Hosen MJ. Silent hypoxia in COVID-19: pathomechanism and possible management strategy. Mol Biol Rep 2021;48:3863-9. [PMID: 33891272 DOI: 10.1007/s11033-021-06358-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]